Journals / Klinik Psikofarmakoloji Bülteni / 2008 / Cilt: 18 - Sayı: 3

Şizofrenide ilaç reçeteleme eğilimindeki değişiklikler

Changes in drug prescription patterns in schizophrenia in five years

Pages
162–166
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It is interesting that antipsychotic combination therapy rates have almost doubled within the period studied and no correlation was found between good drug adherence and the type of antipsychotic used.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this retrospective study is to investigate changes in the prescription patterns for inpatients diagnosed with schizophrenia in 1999 and 2004.
📊
Key Findings & Data:Method: A total of 1218 inpatient admissions to a general hospital adult psychiatry unit in 1999 and 2004 were examined retrospectively.
💡
Conclusion & Impact:It is interesting that antipsychotic combination therapy rates have almost doubled within the period studied and no correlation was found between good drug adherence and the type of antipsychotic used.
🔬Design:Review & Systematic Survey
📍Scope:2004 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: The aim of this retrospective study is to investigate changes in the prescription patterns for inpatients diagnosed with schizophrenia in 1999 and 2004. Method: A total of 1218 inpatient admissions to a general hospital adult psychiatry unit in 1999 and 2004 were examined retrospectively. Total 298 patients (138 in 1999 and 160 in 2004) were diagnosed with schizophrenia according to the criteria of DSM-IV. Demographics and medical data of the patients and the prescribed antipsychotics were reviewed. Chi-square and t-tests were used for statistical analysis. Results: Data showed that typical antipsychotic prescription rate decreased from 53.6% in 1999 to 34.4% in 2004, while the atypical antipsychotic prescription rate increased from 43.5% in 1999 to 54.4% in 2004. Also combined antipsychotic prescription rate (polypharmacy) increased from 11.6% in 1999 to 20% in 2004 and anticholinergic prescription rate decreased from 53.3% in 1999 to 24.4% in 2004. Discussion: The findings of this study confirm the results of previous studies that atypical antipsychotics appear to be displacing typical antipsychotics in the treatment of schizophrenia. It is interesting that antipsychotic combination therapy rates have almost doubled within the period studied and no correlation was found between good drug adherence and the type of antipsychotic used.

Özet

Amaç: 1999 ve 2004 yıllarında şizofreni tanısı ile izlenen yatan hastalarda ilaç reçeteleme eğilimlerindeki değişikliklerin geriye dönük olarak incelenmesi amaçlanmıştır. Yöntem: 1999 ve 2004 yıllarında erişkin psikiyatri kliniğinde yatırılarak takip edilen toplam 1218 hastanın verileri geriye dönük olarak incelenmiştir. 1999 yılı için 138 ve 2004 yılı için 160 olmak üzere DSM-IV kriterlerine göre şizofreni tanısı alan toplamda 298 hasta çalışma grubunu oluşturmuştur. Hastaların demografik ve tıbbi bilgileri ve reçetelenen antipsikotikler gözden geçirilmiştir. İstatistiksel analiz için ki kare ve t - testleri kullanılmıştır. Bulgular: Bulgularımız 1999’da tipik antipsikotik reçeteleme oranı %53.6 iken 2004’te bu oranın %34.4’e düştüğünü; atipik antipsikotik reçeteleme oranının ise 1999–2004 yılları karşılaştırıldığında %43.5’den %54.4’e çıktığını göstermiştir. İki dönem karşılaştırıldığında kombine antipsikotik reçeteleme oranı %11.6’dan %20’ye çıkarken antikolinerjik reçeteleme oranı %53.3’ten %24.4’e düşmüştür. Tartışma: Bu çalışmanın bulguları şizofreni tedavisinde atipik antipsikotiklerin tipik antipsikotiklerin yerini aldığını gösteren çalışmaların sonuçlarını destekler niteliktedir. Kombine tedavi oranlarının artması ve iyi ilaç uyumunun kullanılan antipsikotik türü ile ilişkili bulunmamış olması ilgi çekicidir.

🔖

Cite This Article

ÖRSEL, S., ÖZBAY, M. H., KAHİLOĞULLARI, A. K., SARGIN, A. E., HATILOĞLU, U., BERBER, M. S. (2022). Şizofrenide ilaç reçeteleme eğilimindeki değişiklikler. Klinik Psikofarmakoloji Bülteni, Cilt: 18 - Sayı: 3, 162–166. https://ajindex.com/articles/574312

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Hagen B, Esther CA, Ikuta R, Williams RJ, Le Navenec CL, Aho M. Antipsychotic drug use in Canadian long-term care facilities: prevalence, and patterns following resident relocation. Int Psychogeriatr 2005; 17: 179-193
  2. Davids E, Bunk C, Specka M, Gastpar M. Psychotropic drug prescription in a psychiatric university hospital in Germany. Prog Neuropsychopharmacol Biol Psychiatry. 2006; 30:1109-1116 3. Centorrino F, Eakin M, Bahk W, Kelleher JP, Goren J, Salvatore P et al. Inpatient Antipsychotic Drug Use in 1998, 1993, and 1989. Am J Psychiatry 2002;159:1932-1935
  3. Taylor D, Mir S, Kerwin R. Prescribing in schizophrenia. Evaluating the effect of introducing a new treatment protocol. Psychiatr Bull. 2000; 24: 106-108
  4. Bitter I, Chou JC, Ungvari GS, Tang WK, Xiang Z, Iwanami A et al. Prescribing for Inpatients with Schizophrenia: An International Multi-Center Comparative Study. Pharmacopsychiatry 2003;36:143-149
  5. Rothbard AB, Kuno E, Foley K. Trends in the Rate and Type of Antipsychotic Medications Prescribed to Persons With Schizophrenia. Schizophr Bull 2003; 29:531-540
  6. Martin BC, Miller LS, Kotzan JA. Antipsychotic prescription use and costs for persons with schizophrenia in the 1990s: current trends and five year time series forecasts. Schizophr Res. 2001;47:281-292
  7. Frank RG, Conti RM, Goldman HH. Mental Health Policy and Psychotropic Drugs. Milbank Q.2005; 83:271–298
  8. Hermann RC, Yang D, Ettner SL, Marcus SC, Yoon C, Abraham M. Prescription of Antipsychotic Drugs by Office-Based Physicians in the United States, 1989-1997. Psychiatr Serv. 2002; 53:425-430
  9. Aparasu RR, Bhatara V, Gupta S. US. national trends in the use of antipsychotics during office visits, 1998–2002. Ann Clin Psychiatry. 2005;17:147-152
  10. Santamaria B, Perez M, Montero D, Madurga M, Abajo FJ. Use of antipsychotic agents in Spain through 1985-2000. Eur Psychiatry 2002;17:471-476
  11. Trifiro G, Spina E, Brignoli O, Sessa E, Caputi AP, Mazzaglia G. Antipsychotic prescribing pattern among Italian general practitioners: a population-based study during the years 1999-2002. Eur J Clin Pharmacol. 2005; 61:47-53
  12. Tognoni G. Pharmacoepidemiology of psychotropic drugs in patients with severe mental disorders in Italy. Italian Study Group on the Outcome of Severe Mental Disorders. Eur J Clin Pharmacol.1999; 55:685-690
  13. Divac N, Tosevski DL, Babiç D, Djuriç D, Prostran M, Samardziç R. Trends in consumption of psychiatric drugs in Serbia and Montenegro 2000-2004